RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Camford Capital
C

Camford Capital portfolio

Camford Capital has 1 portfolio company on record at Recent Funding.

Website: camford.vc.
Type: Venture capital.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $106M.
Latest deal: Totus Medicines · Dec 17, 2023.
About this page

It is a venture capital firm based in Menlo Park, US, founded in 2020. Its most recent investment on record is Totus Medicines's $66M Series B+ round in December 2023, alongside DCVC Bio, Regents of The University of Minnesota and Northpond Ventures. That company is in Health and bio. It has co-invested with Northpond Ventures, DCVC Bio and Regents of The University of Minnesota, most often Northpond Ventures (2 rounds).

About Camford Capital

Firm type: Venture capital.
Headquarters: Menlo Park, US.
Founded: 2020.
Stages: Pre-Seed, Seed, Series A.
Sectors: Biotech, Consumer, Data & Infrastructure, Enterprise Software, Fintech, SaaS.

What Camford Capital invests in

How Camford Capital invests

StageDealsCapital in rounds
Series B+ 1 50%$66M
Series A 1 50%$40M
YearDealsCapital in rounds
2021 1 50%$40M
2023 1 50%$66M

Camford Capital portfolio companies

CompanyRound with Camford CapitalTotal raisedLatest raise
TTotus Medicines
Health and bio
Series B+ · $66M$106MDec 17, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 2 rounds on Recent Funding that name Camford Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Camford Capital, which is a subset of its real portfolio. API: /api/v1/investors/camford-capital (get a free API key). More: the most active VC firms and new venture capital funds.